One of the top transcripts that increased with tauopathy but decreased with Nanoligomer treatment was Interleukin 17 Receptor E (IL17RE), which is also associated with the activation of NF-κB [55] and cognitive dysfunction [56]. This evidence concerns the gene NFKB1 and tauopathy.